ARIAD Pharmaceuticals Competitors and Similar CompaniesClear all

ARIAD Pharmaceuticals's competitors and similar companies include GlycoMimetics, Processa Pharmaceuticals and ViroStatics.

	ARIAD Pharmaceuticals ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers.	GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.	Processa Pharmaceuticals Processa Pharmaceuticals (formerly Heatwurx) is a company focused on developing treatments for patients with an unmet medical need.	ViroStatics ViroStatics is a pharmaceutical company.
Founding Date	Founding Date 1991	Founding Date 2003	Founding Date 2017	Founding Date 2005
Type	Type Subsidiary	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Cambridge, US HQ Boston, US Chicago, US Cincinnati, US Dallas, US Minneapolis, US New York, US see more	Locations Rockville, US HQ	Locations Hanover, US HQ	Locations Sassari, IT HQ Tramariglio, IT
Employees	Employees 1381% increase	Employees 5025% increase	Employees 1033% decrease	Employees 8
Valuation ($)	Valuation ($) N/A	Valuation ($) 31.6 m	Valuation ($) 4.4 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $118.8m (FY, 2015)	Revenue (est.) $10.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income ($231.2m) (FY, 2015)	Net income ($153.9m) (FY, 2025)	Net income ($13.6m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 101.8m	Total funding raised N/A	Total funding raised $ 53k